Mylan CEO and leadership

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Abigail Anderson is an Head of Governance and Operations, Global IT at MYLAN INC.; Senior Director, Producer Portfolio Lead - Global IT at MYLAN INC.; and Head of Global Partner (Corporate Functions) IT and Office of the CIO at MYLAN INC. and is based in Greater Pittsburgh Area. She has worked as Senior Consultant at John Muir Health, Consultant at HealthTek Solutions, and VP of Consulting Services at Liberty Solutions. Abigail studied at James Madison University - JMU between 1998 and 2002.

Adriyana Krasteva is a Senior Accountant at MYLAN INC. and Chief Accountant at MYLAN INC. and is based in Bulgaria. She has worked as Accountant at Dekont Accounting Firm and Senior Accountant at Abbott Laboratories. Adriyana attended “Prof. Dr. Assen Zlatarov” Foreign Language School between 1998 and 2003 and University of National and World Economy, Sofia between 2003 and 2008.

Highly-qualified professional with more than 25 years of progressive leadership experience in Information Security within a multi-national pharmaceutical company, seeking information security officer position in medium or large sized multi-national corporation.

Recognized Pharma Industry expert on the creation of standards for digital identity and information security with over 20 years of cyber security experience.

Established multiple years of the corporate-wide information security strategy and roadmap which has served as the basis for the multi-year multi-million-dollar program which has delivered significant risk reduction over the last 5 years of its execution.



12 years of proven experience leading various cyber security operational teams including cyber incident response, application security testing and information leakage prevention.

Over 15 years of experience authoring the board updates on the state of information security, proving the information security updates for external and internal executive reporting including the annual report.

Provided testimony in federal and local courts related security incidents and intellectual property defense.

Defined and delivered the multi-year security strategies for various security domains including mobility, insider threat, secure collaboration, secure hosting and application security.

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.